Neoplasms By Site clinical trials

Explore recruiting neoplasms by site clinical trials.

Recruiting neoplasms by site studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neoplasms By Site trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors

Finland, Norway, Denmark, France, Italy, Austria +3 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Neoplasms By Site trials by city

Neoplasms By Site in Toronto Neoplasms By Site in Vancouver Neoplasms By Site in Montreal Neoplasms By Site in Calgary Neoplasms By Site in Edmonton Neoplasms By Site in Ottawa Neoplasms By Site in Winnipeg Neoplasms By Site in Quebec City Neoplasms By Site in Hamilton Neoplasms By Site in Kitchener Neoplasms By Site in London Neoplasms By Site in Halifax Neoplasms By Site in New York Neoplasms By Site in Los Angeles Neoplasms By Site in Chicago Neoplasms By Site in Houston

Neoplasms By Site clinical trials

Recruiting neoplasms by site studies right now

Exploratory Platform Research on Precision Therapy of Advanced Pancreatic Cancer

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Application of 3D MR Neurogram for Intraparotid Facial Nerves Evaluation

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC)

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Clinical Study of Endocardial Myocardial Biopsy

Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC

FAST-FORWARD vs HAI5

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

Also recruiting in Europe

A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS-986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody (Nivolumab, BMS-936558) in Advanced Solid Tumors

Neoplasms By Site trials by city

Other conditions